PMID: 18200397Jan 18, 2008Paper

The prevalence of metabolic syndrome among psychiatric inpatients in Brazil

Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Paulo José Ribeiro Teixeira, Fábio Lopes Rocha

Abstract

Metabolic syndrome is a highly prevalent disorder among the general population. Studies show an even higher prevalence among psychiatric patients. The objective of this study is to assess the prevalence of metabolic syndrome among inpatients of a psychiatric ward of a general hospital in Brazil and correlate it with their respective psychiatric diagnoses and with the antipsychotics and mood stabilizers used. 170 inpatients (mean age: 45.6 years) were evaluated according to the National Cholesterol Education Program criteria for metabolic syndrome, with a modification of the criteria for blood pressure and fasting glucose. The prevalence found was 29.4%, being higher in women (43.6% versus 20.8%, p = 0.002). The prevalence stratified by psychiatric diagnostic was 48.1% for depression, 38.3% for bipolar disorder, 31.8% for schizophrenia and schizoaffective disorder, 5.1% for alcoholism, and 23.1% for "other mental disorders". The prevalence for alcoholism was significantly lower than the prevalence rates associated with other diagnostic categories (p = 0.035). After using the multivariate analysis, female gender and use of lithium remained as factors associated with a diagnosis of metabolic syndrome. The prevalence found was 29.4...Continue Reading

References

Jan 1, 1987·Neuropsychobiology·P Vestergaard, M Schou
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jan 5, 2002·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·A Barceló, S Rajpathak
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Mar 26, 2003·Journal of Psychiatric Research·Ulrich ZimmermannThomas Pollmächer
May 21, 2003·The Journal of Clinical Psychiatry·Tuula HeiskanenJukka Hintikka
Mar 9, 2004·The Journal of Clinical Psychiatry·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Mar 17, 2004·Current Opinion in Pharmacology·Herbert Y Meltzer
Jun 24, 2004·The American Journal of Clinical Nutrition·Yeong Sook YoonWha Young Kim
Jul 16, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Martha M. KatoMercedes Gonzalez-Blanco
Aug 26, 2004·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Eduardo Pondé de SenaIrismar Reis de Oliveira
Oct 12, 2004·Schizophrenia Research·Ann BagchiStephen Crystal
Oct 27, 2004·Diabetes Care·Mercedes R CarnethonUNKNOWN Coronary Artery Risk Development in Young Adults study
Jan 7, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tony CohnGary Remington
May 14, 2005·The Journal of Clinical Psychiatry·Kaisa M SaariHannu J Koponen
Dec 24, 2005·Revista española de cardiología·Paul ZimmetManuel Serrano Ríos
Jan 20, 2006·International Clinical Psychopharmacology·Staffan HäggRolf Adolfsson
Jan 25, 2006·Journal of Psychiatric Practice·Jonathan MeyerDonna Wirshing

❮ Previous
Next ❯

Citations

Jun 30, 2009·Psychosomatic Medicine·Jess G FiedorowiczWilliam H Coryell
Apr 1, 2009·Acta Neuropsychiatrica·Karla Mathias de AlmeidaBeny Lafer
Jan 29, 2013·Neuropsychiatric Disease and Treatment·Pedro Caldana GordonMario Rodrigues Louzã
Nov 20, 2012·Indian Journal of Psychological Medicine·Sandeep GroverParmanand Kulhara
Aug 21, 2013·Journal of Pharmacology & Pharmacotherapeutics·Rakesh K ChaddaMamta Sood
Sep 21, 2013·Indian Journal of Psychological Medicine·Jitender AnejaKrishan Kumar Kohli
Feb 5, 2009·Current Diabetes Reports·Roger S McIntyreBenjamin I Goldstein
Nov 17, 2009·Current Psychiatry Reports·Dylan P MurrayJess G Fiedorowicz
Feb 11, 2016·Journal of Child and Adolescent Psychopharmacology·Özgür Korhan TunçelBirşen Bilgici
Feb 7, 2012·General Hospital Psychiatry·Isabela M BenseñorPaulo R Menezes
Jun 15, 2010·Journal of Affective Disorders·Roger S McIntyreValerie H Taylor
Jun 25, 2009·Human Psychopharmacology·Maria D MaldonadoMaria A Pérez-San-Gregorio
Mar 19, 2009·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc DE HertRuud VAN Winkel
Oct 8, 2013·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Davy VancampfortMarc De Hert
Nov 11, 2011·CNS Neuroscience & Therapeutics·Karla M de AlmeidaBeny Lafer
Jul 21, 2011·Nordic Journal of Psychiatry·Maj VinbergAnders Fink-Jensen
Jan 9, 2013·Nordic Journal of Psychiatry·Sandeep GroverSavita Malhotra
Apr 10, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Letícia CzepielewskiRodrigo Grassi-Oliveira
Nov 3, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·J BobesUNKNOWN CLAMORS Study Collaborative Group
Nov 8, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sandeep GroverNidhi Chauhan
Apr 24, 2013·Journal of Affective Disorders·Nidhi MalhotraSandeep Grover
Mar 8, 2011·Journal of Psychiatric Research·Mytilee VemuriNatalie L Rasgon
Sep 1, 2013·Revista colombiana de psiquiatría·Carlos López JaramilloJulieta Osorio Zuluaga
May 14, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kai G Kahl, Thomas Hillemacher
Jun 25, 2016·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Davy VancampfortBrendon Stubbs
Aug 29, 2013·Therapeutic Advances in Psychopharmacology·Evangelos Papanastasiou
Mar 13, 2017·Journal of Affective Disorders·Edgar Toschi-DiasNicola Montano
Aug 17, 2018·Cognitive, Affective & Behavioral Neuroscience·Carla M PatistJohn P Headrick
Apr 18, 2009·Harvard Review of Psychiatry·Heather A KennaNatalie L Rasgon
Jan 16, 2019·Early Intervention in Psychiatry·Barbara IruretagoyenaAlfonso Gonzalez-Valderrama
Apr 29, 2009·European Archives of Psychiatry and Clinical Neuroscience·N RichterH-J Assion
Aug 21, 2018·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Stanley C Igwe, Francesco Brigo
Oct 29, 2017·Nutritional Neuroscience·Özge KüçükerdönmezBurak Yıldız
Oct 10, 2013·CNS Spectrums·Donatella MarazzitiLiliana Dell'Osso
Jun 3, 2010·European Archives of Psychiatry and Clinical Neuroscience·M K YaziciS L Tokgözoğlu
Oct 13, 2012·International Review of Psychiatry·Prabha S ChandraVidyendran Rudhran
Aug 5, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ghadah H AlshehriDarren M Ashcroft
Nov 6, 2010·European Archives of Psychiatry and Clinical Neuroscience·Georgios PaslakisMichael Deuschle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here